IIM
CHRS icon

INTECH Investment Management’s Coherus Oncology CHRS Stock Holding History

INTECH Investment Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.3K Buy
31,607
+3,507
+12% +$5.73K ﹤0.01% 2069
2026
Q1 		$47.5K Sell
28,100
-19,961
-42% -$35.4K ﹤0.01% 2008
2025
Q4 		$68.2K Hold
48,061
– – ﹤0.01% 2231
2025
Q3 		$78.8K Sell
48,061
-2,016
-4% -$2.24K ﹤0.01% 2314
2025
Q2 		$36.6K Sell
50,077
-43,642
-47% -$37.7K ﹤0.01% 2436
2025
Q1 		$75.6K Buy
93,719
+66,119
+240% +$76.1K ﹤0.01% 2373
2024
Q4 		$38.1K Buy
+27,600
New +$31K ﹤0.01% 2352

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

INTECH Investment Management's CHRS Position: Q2 2026 in Review

INTECH Investment Management increased its Coherus Oncology (CHRS) stake by 12% in Q2 2026, buying an estimated $5.73K and bringing the position to 31,607 shares worth $44.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2069.

INTECH Investment Management first reported a position in CHRS in Q4 2024 and has held it in 7 quarters since. The position peaked at $78.8K in Q3 2025. 146 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • INTECH Investment Management held 31,607 shares of Coherus Oncology worth $44.3K as of Q2 2026.
  • INTECH Investment Management bought 3,507 Coherus Oncology shares in Q2 2026, an estimated $5.73K.
  • Coherus Oncology made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #2069 holding.
  • INTECH Investment Management first reported a position in Coherus Oncology in Q4 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's Coherus Oncology position peaked at $78.8K in Q3 2025.
  • 146 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.